Journals / Türk Kardiyoloji Derneği Arşivi / 2012 / Cilt: 40 - Sayı: 8

Metabolik sendrom varlığı ve ciddiyeti ile atriyuma ait elektromekanik gecikme ve P dalga dispersiyonu arasındaki ilişki

The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome

Pages
663–670
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Both inter-AEMD (22.9±15 vs. 11.5±14, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, we aimed to investigate the association between the presence and severity of metabolic syndrome (MetS) with intra- and inter-atrial electromechanical delay (AEMD) and P-wave dispersion (PWD).
📊
Key Findings & Data:Study design: A total of 144 patients (72 MetS patients and 72 age- and sex-matched control subjects) were included in the study.
💡
Conclusion & Impact:Results: Both inter-AEMD (22.9±15 vs. 11.5±14, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, we aimed to investigate the association between the presence and severity of metabolic syndrome (MetS) with intra- and inter-atrial electromechanical delay (AEMD) and P-wave dispersion (PWD). Study design: A total of 144 patients (72 MetS patients and 72 age- and sex-matched control subjects) were included in the study. Patients with MetS were classified into three groups based on the number of MetS criteria as follows: Group 1 (patients with three MetS criteria), Group 2 (patients with four MetS criteria) and Group 3 (patients with five MetS criteria). Intra- and inter-AEMD were measured from parameters of tissue Doppler imaging. PWD was calculated from the 12-lead electrocardiogram. Results: Both inter-AEMD (22.9±15 vs. 11.5±14, p

Özet

Amaç: Bu çalışmada, atriyum içi ve atriyumlar arası elektromekanik gecikme (AEMG) ve P dalga dispersiyonu (PDD) ile metabolik sendrom (MetS) varlığı ve şiddeti arasındaki ilişki incelendi. Çalışma planı: Çalışmaya MetS olan (n=72) ve olmayan (kontrol grubu, n=72) toplam 144 hasta alındı. MetS ciddiyetinin belirlenmesi için hastalar MetS ölçütlerinin sayısına göre üç gruba ayrıldı: Grup 1 (üç ölçütlü hastalar), Grup 2 (dört ölçütlü hastalar) ve Grup 3 (beş ölçütlü hastalar). Hastaların 12 derivasyonlu elekrokardiyografilerinden PDD ve doku Doppler parametrelerinden kulakçıklar arası ve kulakçıklar içi AEMG hesaplandı. Bulgular: Kulakçılar arası AEMG (22.9±15 ve 11.5±14, p

🔖

Cite This Article

TANBOĞA, İ. H., BÜYÜKKAYA, E., AKCAY, A. B., KARAKAŞ, M. F., KURT, M., ŞEN, N., BİLEN, E. (2022). Metabolik sendrom varlığı ve ciddiyeti ile atriyuma ait elektromekanik gecikme ve P dalga dispersiyonu arasındaki ilişki. Türk Kardiyoloji Derneği Arşivi, Cilt: 40 - Sayı: 8, 663–670. https://ajindex.com/articles/633054

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kabakcı G, Aydın M, Demir I, Kırma C, Özerkan F. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey. Turk Kardiyol Dern Ars 2010;38:313-20
  2. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6
  3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52
  4. Stewart S, Hart CL, Hole DJ, McMurray JJ. A populationbased study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64
  5. Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, et al. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol 2011;108:227-32
  6. Omi W, Nagai H, Takamura M, Okura S, Okajima M, Furusho H, et al. Doppler tissue analysis of atrial electromechanical coupling in paroxysmal atrial fibrillation. J Am Soc Echocardiogr 2005;18:39-44
  7. Isik T, Tanboga IH, Kurt M, Kaya A, Ekinci M, Ayhan E, et al. Relation of the metabolic syndrome with proarrhythmogenic electrocardiographic parameters in patients without overt diabetes. Acta Cardiol 2012;67:195-201
  8. Ermiş N, Açıkgöz N, Yaşar E, Taşolar H, Yağmur J, Cansel M, et al. Evaluation of atrial conduction time by P wave dispersion and tissue Doppler echocardiography in prehypertensive patients. Turk Kardiyol Dern Ars 2010;38:525-30
  9. Altun B, Acar G, Akçay A, Sökmen A, Kaya H, Köroğlu S. Comparative effects of nebivolol and valsartan on atrial electromechanical coupling in newly diagnosed stage 1 hypertensive patients. Turk Kardiyol Dern Ars 2011;39:563-7
  10. Chamberlain AM, Agarwal SK, Ambrose M, Folsom AR, Soliman EZ, Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010;159:850-6
  11. Vyssoulis G, Karpanou E, Adamopoulos D, Kyvelou SM, Tzamou V, Michaelidis A, et al. Metabolic syndrome and atrial fibrillation in patients with essential hypertension. Nutr Metab Cardiovasc Dis 2011
  12. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atri